{"visible": {"type": 0, "list_id": 0}, "created_at": "Mon Feb 03 12:58:11 +0800 2020", "id": 4467866693187633, "idstr": "4467866693187633", "mid": "4467866693187633", "mblogid": "Istwpdnfr", "user": {"id": 3176105483, "idstr": "3176105483", "pc_new": 7, "screen_name": "苍龙飞天79", "profile_image_url": "https://tvax1.sinaimg.cn/default/images/default_avatar_male_50.gif?KID=imgbed,tva&amp;Expires=1713180886&amp;ssig=g18v7SROu%2F", "profile_url": "/u/3176105483", "verified": true, "verified_type": 0, "domain": "", "weihao": "275991179", "verified_type_ext": 2, "avatar_large": "https://tvax1.sinaimg.cn/default/images/default_avatar_male_180.gif?KID=imgbed,tva&amp;Expires=1713180886&amp;ssig=qEknJEsVvZ", "avatar_hd": "https://tvax1.sinaimg.cn/default/images/default_avatar_male_180.gif?KID=imgbed,tva&amp;Expires=1713180886&amp;ssig=qEknJEsVvZ", "follow_me": false, "following": false, "mbrank": 2, "mbtype": 12, "v_plus": 1, "planet_video": false, "icon_list": [{"type": "vip", "data": {"mbrank": 2, "mbtype": 12, "svip": 1, "vvip": 1}}, {"type": "icon", "data": {"value": "1", "icon_img": "https://h5.sinaimg.cn/upload/106/1683/2024/03/07/feed_icon_2024lvzhi2x.png", "title": "绿植领养", "url": "https://s.weibo.com/weibo?q=%23绿植领养%23"}}, {"type": "icon", "data": {"value": "1", "icon_img": "https://h5.sinaimg.cn/upload/106/1683/2024/03/07/feed_icon_2024chuntian2x.png", "title": "你好春天", "url": "https://s.weibo.com/weibo?q=%23你好春天%23"}}]}, "can_edit": false, "text_raw": "转自【影视八条街】——白宫官网消息：吉利德公司的瑞德西韦明日（2月3日）开始在中国临床试验。经特朗普总统特批，同意将该药物专利豁免，向中国紧急公开药物分子结构。允许中国仿制此药用于治疗冠状病毒。目前，Gilead的Remdesivir在中国的随机、双盲、对照III期临床研究迅速启动，总样本量270例，入 ​​​", "textLength": 631, "annotations": [{"client_mblogid": "e22fc7cb-9352-4336-af7b-7270a1d0a9e6"}, {"mapi_request": true}], "source": "&lt;a target=\"_blank\" href=\"https://app.weibo.com/t/feed/5Nu7MV\" rel=\"nofollow\"&gt;华为P9手机摄影再突破&lt;/a&gt;", "favorited": false, "rid": "0_0_0_5243560129568376422_0_0_0", "pic_ids": ["bd4f860bgy1gbj4ihffi9j20dw08edfu"], "pic_num": 1, "pic_infos": {"bd4f860bgy1gbj4ihffi9j20dw08edfu": {"thumbnail": {"url": "https://wx2.sinaimg.cn/wap180/bd4f860bgy1gbj4ihffi9j20dw08edfu.jpg", "width": 180, "height": 108, "cut_type": 1, "type": null}, "bmiddle": {"url": "https://wx2.sinaimg.cn/wap360/bd4f860bgy1gbj4ihffi9j20dw08edfu.jpg", "width": 360, "height": 217, "cut_type": 1, "type": null}, "large": {"url": "https://wx2.sinaimg.cn/orj960/bd4f860bgy1gbj4ihffi9j20dw08edfu.jpg", "width": 500, "height": 302, "cut_type": 1, "type": null}, "original": {"url": "https://wx2.sinaimg.cn/orj1080/bd4f860bgy1gbj4ihffi9j20dw08edfu.jpg", "width": 500, "height": 302, "cut_type": 1, "type": null}, "largest": {"url": "https://wx2.sinaimg.cn/large/bd4f860bgy1gbj4ihffi9j20dw08edfu.jpg", "width": 500, "height": 302, "cut_type": 1, "type": null}, "mw2000": {"url": "https://wx2.sinaimg.cn/mw2000/bd4f860bgy1gbj4ihffi9j20dw08edfu.jpg", "width": 500, "height": 302, "cut_type": 1, "type": null}, "largecover": {"url": "https://wx2.sinaimg.cn/cmw960/bd4f860bgy1gbj4ihffi9j20dw08edfu.jpg", "width": 500, "height": 302, "cut_type": 1, "type": null}, "object_id": "1042018:9afea8883c005448e749f2241d86b4a9", "pic_id": "bd4f860bgy1gbj4ihffi9j20dw08edfu", "photo_tag": 0, "type": "pic", "pic_status": 1}}, "is_paid": false, "mblog_vip_type": 0, "number_display_strategy": {"apply_scenario_flag": 3, "display_text_min_number": 1000000, "display_text": "100万+"}, "reposts_count": 0, "comments_count": 17, "attitudes_count": 22, "attitudes_status": 0, "continue_tag": {"title": "全文", "pic": "http://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_article.png", "scheme": "sinaweibo://detail?mblogid=4467866693187633&amp;id=4467866693187633&amp;next_fid=232532_mblog&amp;feed_detail_type=0"}, "isLongText": true, "mlevel": 128, "complaint": {"showcontent": "此内容为不实消息，已处理。", "color": 1, "url": "http://service.account.weibo.com/show?rid=K1CaS7Q5h8a4j", "actionlog": {"act_code": 6528, "fid": null, "lfid": null, "uicode": null, "luicode": null, "ext": "uid:3176105483|mid:4467866693187633|mlevel:128"}}, "content_auth": 0, "is_show_bulletin": 2, "comment_manage_info": {"comment_permission_type": -1, "approval_comment_type": 0, "comment_sort_type": 0}, "share_repost_type": 0, "title": {"text": "公开", "base_color": 1, "icon_url": "http://h5.sinaimg.cn/upload/2015/07/14/34/timeline_title_public.png"}, "mblogtype": 0, "showFeedRepost": false, "showFeedComment": false, "pictureViewerSign": false, "showPictureViewer": false, "rcList": [], "text": "转自【影视八条街】——白宫官网消息：吉利德公司的瑞德西韦明日（2月3日）开始在中国临床试验。经特朗普总统特批，同意将该药物专利豁免，向中国紧急公开药物分子结构。允许中国仿制此药用于治疗冠状病毒。目前，Gilead的Remdesivir在中国的随机、双盲、对照III期临床研究迅速启动，总样本量270例，入 ​​​ ...&lt;span class=\"expand\"&gt;展开&lt;/span&gt;", "customIcons": [], "ok": 1, "proof": "经查，此微博称“经特朗普总统特批，同意将该药物专利豁免，向中国紧急公开药物分子结构。允许中国仿制此药用于治疗冠状病毒患者”不实，据@环球时报 记者发现这事并不存在。详情：https://weibo.com/1974576991/IsuVnAjmV，被举报人言论构成“发布不实信息”。现根据《微博举报投诉操作细则》（<http://service.account.weibo.com/roles/guiding>）第19条，对被举报人处理如下：扣除信用积分2分。上述处理在公布后60分钟内生效。"}